TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Diastolic dysfunction parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: locoregional tumor control
Endpoint domain: Mortality/survival
Primary endpoint: Completion of detoxification medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion providing a clean urine sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abstinence at three and six months post detoxification
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Collagen volume fraction (CVF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left ventricular chamber stiffness (K(LV))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in portal blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rise in cardiac output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease in peripheral vascular resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Postoperative cognitive function (MMSE scores)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Intracranial pressure (evidence of IJVVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean breastfeeding duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyperglycaemic and hypoglycaemic distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fatigue distress
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Cardiovascular distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complications during stent placement
Endpoint domain: Adverse events/effects
Primary endpoint: Dyspnea score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: duration of fluoroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total Daily Dose (TDD) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Body mass (BM) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: frequency of early vascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Standardized mean difference (SMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-rated improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum quercetin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left atrial appendage function (emptying and filling flow velocities)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Urinary cadmium level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Abnormal rate of urinary cadmium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic balance of urinary Ca, Cu, Zn and I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Consumption of sevoflurane
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Occurrence of dysphoria
Endpoint domain: Adverse events/effects
Primary endpoint: Serum CRP concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median achieved survival
Endpoint domain: Mortality/survival
Primary endpoint: Median overall response duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alanine aminotransferase and aspartataminotransferase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biochemical and histologic remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical success rate of restorations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean survival time of restorations
Endpoint domain: Mortality/survival
Primary endpoint: Median time at maximal concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of Communication
Endpoint domain: Life impact
Endpoint subdomain: Communication
Primary endpoint: Background Noise
Endpoint domain: Life impact
Endpoint subdomain: Environmental factors
Primary endpoint: Reverberation
Endpoint domain: Life impact
Endpoint subdomain: Environmental factors
Primary endpoint: Hearing thresholds improvement at high frequencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Step Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in bone pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary obstetric outcome
Endpoint domain: Mortality/survival
Primary endpoint: Primary neonatal outcome
Endpoint domain: Mortality/survival
Primary endpoint: Bayley‐III cognitive composite score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Successful resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Bone resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent change in left ventricular mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SAS with therapeutic taping at 60° of shoulder abduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in SAS with therapeutic taping during SAS0°-60°
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SAS with therapeutic taping during arm resting at 0° of abduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early detection of parenting and child-developmental problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma hydrophilic ORAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urine ORAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hydrophilic/lipophilic ORAC for the food
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GH response to ghrelin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Overall clinical success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient recall rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean AUC0-infinity of atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination half-life of atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RV-ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: local tissue oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mucociliary clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Preventing functional dependency
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Induced incomitance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxidized LDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total atheroma volume (TAV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent atheroma volume (PAV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Follow-up low-density lipoprotein cholesterol (LDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: nausea and vomiting incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Maternal anxiety during the preoperative period
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children's anxiety on entrance to the operating room
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children's anxiety during introduction of the anesthesia mask
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 1-year primary patency rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in students using shaded areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunosuppression level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hospital admissions for exacerbation of COPD
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Unscheduled physician visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: EuroQol‐5D
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Radiographic restoration of alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy for self-management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Propofol dosage required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety levels before the procedure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oxygen saturation decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New-onset AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite end points
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Doppler-derived parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decline in post-exercise FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in cocaine use days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peptic ulcer relapse-free time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Female Sexual Function Index improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in sexual dysfunction frequencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meeting intervention targets for resistance training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meeting intervention targets for aerobic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔGLP‐1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: flow-mediated dilation (FMD) in the brachial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: initial claudication distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: absolute claudication distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: At least 75% improvement in PASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Cleared or minimal disease according to physician's global assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: work productivity loss
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: daily activity impairment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: mean pulmonary artery wedge pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with complete septum resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of pulmonary hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of CLD in survivors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative cardiac troponin I increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: WOMAC stiffness improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pain outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Disability outcomes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postoperative complications due to hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrence of rectal lesions
Endpoint domain: Adverse events/effects
Primary endpoint: decreased pain or swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interval without complications
Endpoint domain: Mortality/survival
Primary endpoint: VT recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Acute success (no VT inducibility after procedure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Misidentification rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommendation rates for first-line treatments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to treatment failure for 1st-line therapy (TTF1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiotherapist satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: frequency of favorable neurologic outcomes (independent living)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average daily pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary frequency reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good neurological outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Good functional outcome (modified Rankin scale 0-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: healthcare resource use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: satisfaction with health care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: quality of life during treatment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: anterior perineal tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Absorption rate of Sulfadoxine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chance of good outcome
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: risk for fatal brain hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: functional outcome changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mental health scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean relative change of the numeric pain rating scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30% and 50% responder rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ear pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time savings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: psychotherapy attendance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recognition rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adherence to depression screening
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: feasibility of screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Varicella-related hospitalization rate
Endpoint domain: Mortality/survival
Primary endpoint: IOP reduction in millimeters of mercury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: IOP reduction percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Reduction in TQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically meaningful improvement in tinnitus
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: increase in fruit intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reduction in total saturated fat intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mental composite scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diagnostic reader agreement accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAS28-CRP changes from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with esthetic outcome
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time consumed for first insertion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction of women's pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Deterioration of respiratory status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Safety and tolerability of riluzole
Endpoint domain: Adverse events/effects
Primary endpoint: Time to first distant failure
Endpoint domain: Mortality/survival
Primary endpoint: Local Progression-Free Survival (LPFS)
Endpoint domain: Mortality/survival
Primary endpoint: ESR1 mutation detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: PIK3CA mutation detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Discordancy rate for mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: complete AK clearance rates per hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: thickness of the subepidermal collagen band
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: ratings regarding mottled pigmentation and overall appearance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ejection fraction at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: infarct mass reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Attention-deficit/hyperactivity disorder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy scores for breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean pH drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC(0‐infinity))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of colorectal cancer (CRC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: retinal sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of cerebrovascular events
Endpoint domain: Mortality/survival
Primary endpoint: plasma renin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reactions to plasma supernatant
Endpoint domain: Adverse events/effects
Primary endpoint: Inter-observer correlation coefficient agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive predictive value for clinical GTPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for clinical GTPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived pleasantness rating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Basal anxiety level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-related hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: liver transection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: blood loss during liver transaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: lipid-lipoprotein profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h leucine oxidation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: clinical clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hypopigmented atrophic scarring
Endpoint domain: Adverse events/effects
Primary endpoint: overall cosmetic appearance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status